The American Journal of Psychiatry’s (AJP) January issue is dedicated entirely to psychedelics, marking “a moment of legitimacy for what was once considered a fringe, fledgling movement driven solely by a select group of zealously dedicated scientists and clinicians”, according to AJP Editor in Chief Ned Kalin and guest editors Gregory Fonzo and Charles Nemeroff, co-directors of Dell Medical…
